The largest database of trusted experimental protocols

2 protocols using anti mouse b220 pe

1

Characterization of Murine Leukemic Lineages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Analyses of leukemic lineages and apoptosis were performed as described earlier [6 (link)]. Briefly, for analysis of lineages and LICs, bone marrow cells were stained with anti-mouse Mac-1-PE, anti-mouse Gr-1-APC, anti-mouse CD3e-PE, anti-mouse B220-PE, and anti-mouse c-Kit-APC monoclonal antibodies (eBioscience, USA). For detection of CD274 expression in Mac-1+/c-Kit+ LICs of murine AML model, anti-mouse CD274-biotin and streptavidin-PE (secondary antibody) were used (eBioscience, USA). Cell cycle status was determined in purified Mac-1+/c-Kit+ LICs with Pyronin Y and Hoeschst 33342 staining (Sigma, USA) as previously described [25 (link)]. Apoptosis analysis was conducted in purified Mac-1+/c-Kit+ LICs with anti-Annexin V-PE and 7-AAD staining (BD Pharmingen, USA) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
2

Analysis of Leukemia Cell Phenotype and Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood was collected by retro-orbital bleeding, and bone marrow cells were isolated from the femurs and tibias of leukemic mice. Flow cytometry and cell cycle analyses were performed as we described previously [47 (link)]. Briefly, leukemia cells were stained with anti-mouse Mac-1-APC, anti-mouse Gr-1-PE, anti-mouse CD3-APC, anti-mouse B220-PE or anti-mouse c-Kit-PE monoclonal antibodies (eBioscience). The cell cycle stages were evaluated with either Ki-67/7-AAD staining (BD Pharmingen) or a 5-bromo-2′-deoxyuridine (BrdU) incorporation assay. For the analysis of apoptosis, leukemia cells were stained with PE-conjugated anti-Annexin V and 7-AAD (BD Pharmingen) according to the manufacturer's protocol. For the measurement of ROS, the cells were incubated with 1 μM 5-(and-6)-carboxy-2′,7′-dichlorofluorescein diacetate (carboxy-DCFDA, Invitrogen) for 30 minutes at 37°C, followed by flow cytometric analysis. For the examination of the BrdU incorporation assay, leukemic mice were subjected to three intraperitoneal injections of BrdU (Sigma; 3 mg/24 hours) in PBS. The BM cells were fixed, permeabilized and denatured, followed by antibody staining with anti–BrdU-APC according to the manufacturer's instructions (BD Pharmingen).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!